Levamisole HCI | Levamisole hydrochloride | (-)-Tetramisole hydrochloride;(−)-Levamisole (hydrochloride);L-Tetramisole;R 12654;NSC 177023 | Alkaline Phosphatase Inhibitor | Insect Repellent | AChR

首页 / / / / Levamisole HCI

盐酸左旋咪唑 /Levamisole HCI {[allProObj[0].p_purity_real_show]}

货号：A121733 同义名： (-)-Tetramisole hydrochloride;(−)-Levamisole (hydrochloride)

Levamisole HCl is a nAChR agonist used as an anthelmintic to treat worm infestations.

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

Levamisole HCI 化学结构
CAS号：16595-80-5

Levamisole HCI 3D分子结构
CAS号：16595-80-5

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Levamisole HCI 纯度/质量文件产品仅供科研

货号：A121733 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

AChR 亚型比较

产品名称	AChE ↓ ↑	AChR ↓ ↑	mAChR ↓ ↑	nAChR ↓ ↑	其他靶点	纯度
Donepezil	+++ hAChE, IC50: 11.6 nM bAChE, IC50: 8.12 nM					98%
Loganin	++ AChE, IC50: 3.95 μM					99%+
topride HCl	++ AChE, IC50: 2.04 μM					98%
Dehydroevodiamine HCl	✔					99%+
Jatrorrhizine	++ AChE, IC50: 872 nM					99%+
Palmatine	++ AChE, IC50: 0.51 μM					98%
(-)-Huperzine A	++++ AChE (G4 form), Ki: 7 nM					98%
Galanthamine HBr	++ AChE, IC50: 0.35 μM					98%
Trospium chloride		✔				99%
Tiotropium Bromide Monohydrate		✔				98+%
Gallamine Triethiodide		+ AChR, IC50: 68.0 μM				98%
Hexamethonium Bromide		✔				99%
Pancuronium dibromide		✔				98%
Neostigmine bromide		✔				98%
Orphenadrine citrate		✔				98%
Oxybutynin		✔				98%
Irsogladine		✔			PDE	98%
Pyridostigmine bromide		✔				99+%
Rivastigmine		+ AChR, IC50: 5.5 μM				98%
Paroxetine hydrochloride		✔				97%
Rocuronium Bromide		✔				98%
Tropicamide			+++ M4 mAChR, IC50: 8 nM			98%
Diphenmanil methylsulfate			✔			98%
Umeclidinium bromide			✔			95%
Otilonium bromide			✔			98%
Flavoxate HCl			+ mAChR, IC50: 12.2 μM			98%
Ipratropium bromide			✔			98%
Diphenidol HCl			✔			98%
Darifenacin hydrobromide			++++ M3 mAChR, pKi: 8.9			98%
Aclidinium Bromide			++++ M4 mAChR, Ki: 0.21 nM M2 mAChR, Ki: 0.1 nM			98%
Oxybutynin chloride			✔			99%
Pentoxyverine citrate			✔			98%
Solifenacin			✔			98%
Catharanthine				✔		98%
Benzethonium chloride				+++ α4β2 nAChRs, IC50: 49 nM α7 nAChRs, IC50: 122 nM		99+%
Vinblastine sulfate				+ nAChR, IC50: 8.9 μM		99%
PNU-120596				++ α7 nAChR, EC50: 216 nM		99+%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Levamisole HCI 生物活性

描述

Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV. Levamisole suppresses the production of white blood cells, resulting in neutropenia and agranulocytosis. With the increasing use of levamisole as an adulterant, a number of these complications have been reported among cocaine users^[3]. Levamisole reversibly and noncompetitively inhibits most isoforms of alkaline phosphatase (e.g., human liver, bone, kidney, and spleen) except the intestinal and placental isoform^[4]. There was no benefit of a single-dose of levamisole hydrochloride as adjuvant to intravenous artesunate in the treatment of adults with severe falciparum malaria. Rapid parasite killing by intravenous artesunate might obscure the effects of levamisole^[5]. Using BALB/c mice with experimental allergic rhinitis, levamisole delivered locally (intranasal, i.n.) could attenuate early-phase inflammatory response, decrease histamine, suppress edema and eosinophil infiltration, and diminish the ovalbumin-specific serum IgE level. Levamisole can decrease IL-4, IL-5 and IL-13 mRNA and increase IL-12, IL-18 and IFN-gamma mRNA^[6].

Levamisole HCI 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT03432364	Transfusion Dependent Beta-tha... 展开 >>lassemia 收起 <<	Phase 1 Phase 2	Recruiting	May 2022	United States, California ... 展开 >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095-1678 Contact: Nikki Alimi, ANP-BC 310-794-0242 NAlimi@mednet.ucla.edu Contact: Bruck Habtemariam 310-794-0242 bhabtemariam@mednet.ucla.edu Principal Investigator: Gary Schiller, M.D. UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Julie Decaris 510-428-3885 ext 2739 jdecaris@mail.cho.org Principal Investigator: Mark Walters, MD United States, Massachusetts Dana-Farber Boston Children's Cancer and Blood Disorders Center Recruiting Boston, Massachusetts, United States, 02116 Contact: Colleen Dansereau, M.S.N., R.N. 617-919-7008 colleen.dansereau@childrens.harvard.edu Principal Investigator: David A Williams, M.D. United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela Smith, M.D., M.S. 612-625-7253 smith719@umn.edu Contact: Jennifer Braun, R.N., BSN 612-625-0084 danie659@umn.edu Principal Investigator: Angela Smith, M.D., M.S. 收起 <<
NCT03141970	Nephrotic Syndrome	Phase 3	Recruiting	March 31, 2022	United States, California ... 展开 >> Cedars-Sinai Medical Center, Pediatric IBD & Pediatric Nephrology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Jessica Reece, MA 310-423-5314 jessica.reece@cshs.org Principal Investigator: Elaine S Kamil, MD Stanford University Medical Center, Department of Pediatrics, Division of Nephrology Not yet recruiting Stanford, California, United States, 94305 Contact: Maira Simas 650-725-8327 mnsimas@standford.edu Principal Investigator: Gia J Oh, MD United States, Michigan University of Michigan Department of Pedatric Nephrology Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Brenda S Buckle, MSN 734-232-4830 bbuckle@med.umich.edu Contact: Hailey Desmond, MS 734 232 4830 heturner@med.umich.edu Principal Investigator: Debbie Gipson, MD United States, North Carolina Levine's Children/Carolinas HealthCare System Not yet recruiting Charlotte, North Carolina, United States, 28207 Contact: Jennifer Lamothe, RN,BSN,CCRC 704-347-4052 jennifer.lamothe@carolinas.org Principal Investigator: Susan Massengill, MD India All India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Arvind Bagga, MD 911126593472 arvindbagga@hotmail.com Contact: Aditi Sinha, MD 919899145489 aditisinhaaiims@gmail.com Principal Investigator: Arvind Bagga, MD Sub-Investigator: Aditi Sinha, MD Sub-Investigator: Pankaj Hari, MD 收起 <<
NCT02878564	Schistosomiasis Mansoni ... 展开 >> HIV 收起 <<	Phase 4	Completed	-	Uganda ... 展开 >> UVRI-IAVI HIV Vaccine program Entebbe, Wakiso, Uganda 收起 <<

Levamisole HCI 参考文献

[1]Khan FA, Sanyal PK, et al. Comparative anthelmintic activity of strategic sustained low-level administration of albendazole in feed pellets compared to single doses of closantel and tetramisole against natural ovine parasitic gastroenteritis. Trop Anim Health Prod. 1999 Aug;31(4):193-204.

[2]Blach-Olszewska Z, Zaczynska E. Influence of L-tetramisole on the interferon production by mouse peritoneal and L929 cells. Arch Immunol Ther Exp (Warsz). 1991;39(5-6):597-604.

[3]Zhu NY, Legatt DF, Turner AR. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med. 2009 Feb 17;150(4):287-9

[4]Van Belle H. Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem. 1976 Jul;22(7):972-6

[5]Maude RJ, Silamut K, Plewes K, Charunwatthana P, Ho M, Abul Faiz M, Rahman R, Hossain MA, Hassan MU, Bin Yunus E, Hoque G, Islam F, Ghose A, Hanson J, Schlatter J, Lacey R, Eastaugh A, Tarning J, Lee SJ, White NJ, Chotivanich K, Day NP, Dondorp AM. Randomized controlled trial of levamisole hydrochloride as adjunctive therapy in severe falciparum malaria with high parasitemia. J Infect Dis. 2014 Jan 1;209(1):120-9

[6]Wang H, Zhang J, Gao C, Zhu Y, Wang C, Zheng W. Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis. Eur J Pharmacol. 2007 Dec 22;577(1-3):162-9

Levamisole HCI 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

4.15mL

0.83mL

0.42mL

20.77mL

4.15mL

2.08mL

41.54mL

8.31mL

4.15mL

Levamisole HCI 技术信息

CAS号	16595-80-5
分子式	C₁₁H₁₃ClN₂S
分子量	240.752

别名	(-)-Tetramisole hydrochloride;(−)-Levamisole (hydrochloride);L-Tetramisole;R 12654;NSC 177023
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Inert atmosphere,Room temperature

溶解度

DMSO: 15 mg/mL(62.3 mM)，配合低频超声，并水浴加热至45℃助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

H₂O: 50 mg/mL(207.68 mM)，配合低频超声助溶

无水乙醇: 12.5 mg/mL(51.92 mM)，配合低频超声助溶，注意：无水乙醇开封后，易挥发，也会吸收空气中的水分，导致溶解能力下降，请避免使用开封较久的乙醇

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT03432364	Transfusion Dependent Beta-tha... 展开 >>lassemia 收起 <<	Phase 1 Phase 2	Recruiting	May 2022	United States, California ... 展开 >> University of California, Los Angeles Recruiting Los Angeles, California, United States, 90095-1678 Contact: Nikki Alimi, ANP-BC 310-794-0242 NAlimi@mednet.ucla.edu Contact: Bruck Habtemariam 310-794-0242 bhabtemariam@mednet.ucla.edu Principal Investigator: Gary Schiller, M.D. UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Julie Decaris 510-428-3885 ext 2739 jdecaris@mail.cho.org Principal Investigator: Mark Walters, MD United States, Massachusetts Dana-Farber Boston Children's Cancer and Blood Disorders Center Recruiting Boston, Massachusetts, United States, 02116 Contact: Colleen Dansereau, M.S.N., R.N. 617-919-7008 colleen.dansereau@childrens.harvard.edu Principal Investigator: David A Williams, M.D. United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela Smith, M.D., M.S. 612-625-7253 smith719@umn.edu Contact: Jennifer Braun, R.N., BSN 612-625-0084 danie659@umn.edu Principal Investigator: Angela Smith, M.D., M.S. 收起 <<
NCT03141970	Nephrotic Syndrome	Phase 3	Recruiting	March 31, 2022	United States, California ... 展开 >> Cedars-Sinai Medical Center, Pediatric IBD & Pediatric Nephrology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Jessica Reece, MA 310-423-5314 jessica.reece@cshs.org Principal Investigator: Elaine S Kamil, MD Stanford University Medical Center, Department of Pediatrics, Division of Nephrology Not yet recruiting Stanford, California, United States, 94305 Contact: Maira Simas 650-725-8327 mnsimas@standford.edu Principal Investigator: Gia J Oh, MD United States, Michigan University of Michigan Department of Pedatric Nephrology Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Brenda S Buckle, MSN 734-232-4830 bbuckle@med.umich.edu Contact: Hailey Desmond, MS 734 232 4830 heturner@med.umich.edu Principal Investigator: Debbie Gipson, MD United States, North Carolina Levine's Children/Carolinas HealthCare System Not yet recruiting Charlotte, North Carolina, United States, 28207 Contact: Jennifer Lamothe, RN,BSN,CCRC 704-347-4052 jennifer.lamothe@carolinas.org Principal Investigator: Susan Massengill, MD India All India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Arvind Bagga, MD 911126593472 arvindbagga@hotmail.com Contact: Aditi Sinha, MD 919899145489 aditisinhaaiims@gmail.com Principal Investigator: Arvind Bagga, MD Sub-Investigator: Aditi Sinha, MD Sub-Investigator: Pankaj Hari, MD 收起 <<
NCT02878564	Schistosomiasis Mansoni ... 展开 >> HIV 收起 <<	Phase 4	Completed	-	Uganda ... 展开 >> UVRI-IAVI HIV Vaccine program Entebbe, Wakiso, Uganda 收起 <<
NCT01422304	-		Completed	-	-
NCT00715104	Prostate Cancer	Phase 2	Completed	-	United States, California ... 展开 >> USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Oregon Kaiser Permanente Portland Portland, Oregon, United States, 97227 Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Utah University of Utah School of Medicine Salt Lake City, Utah, United States, 84132 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Seattle Cancer Care Alliance Seattle, Washington, United States, 98102 收起 <<
NCT02763475	Acute Myeloid Leukemia ... 展开 >> Leukemia Myeloid Leukemia 收起 <<	Phase 2	Recruiting	February 2022	Spain ... 展开 >> Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Principal Investigator: Itciar Astigarraga Aguirre, MD Hospital Materno Infantil de Badajoz Recruiting Badajoz, Spain, 06010 Principal Investigator: Jose Manuel Vagace Valero, MD Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact 0034913908868 Principal Investigator: José Luis Vivanco Martínez, MD. Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: María Posada, MSc. 0034912071466 maria.posada@idipaz.es Contact: Alicia Herranz Estelles, MD, MSc 0034912071466 alicia.herranz@idipaz.es Principal Investigator: Antonio Pérez Martínez, MD, PhD Hospital de la Arrixaca Recruiting Murcia, Spain, 30120 Principal Investigator: José Luis Fuster, MD Hospital Materno-Infantil de Málaga Recruiting Málaga, Spain, 29011 Principal Investigator: Antonia Pascual Martínez, MD 收起 <<
NCT01380327	Asthma Perenn... 展开 >>ial Allergic Rhinitis 收起 <<	Phase 1 Phase 2	Completed	-	United States, Illinois ... 展开 >> Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Maryland Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21287 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 收起 <<
NCT00715104	-		Completed	-	-
NCT00520130	-		Active, not recruiting	-	-
NCT01380327	-		Completed	-	-
NCT00520130	Myelodysplastic Syndrome ... 展开 >> Hodgkin's Lymphoma Non-Hodgkin's Disease Acute Leukemia Multiple Myeloma 收起 <<	Phase 1 Phase 2	Active, not recruiting	December 2018	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT02527941	Bacterial Vaginosis ... 展开 >> HIV Infections 收起 <<	Phase 1	Completed	-	Kenya ... 展开 >> Kenya AIDS Vaccine Initiative Clinic Nairobi, Kenya 收起 <<
NCT00450463	Prostate Cancer	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 <<
NCT00988065	Hypersensitivity	Phase 1	Completed	-	-
NCT01422304	Neuromuscular Blockade ... 展开 >> Arthroplasty, Replacement, Hip Arthroplasty, Replacement, Knee Blood Coagulation Antithrombotic Agents 收起 <<	Phase 3	Completed	-	-
NCT02503150	Metastatic Colorectal Cancer	Phase 3	Not yet recruiting	December 2020	-
NCT00988065	-		Completed	-	-
NCT02366884	Neoplasms	Phase 2	Enrolling by invitation	December 31, 2020	United States, Maryland ... 展开 >> Atavistic Chemotherapy Clinical Trial Bethesda, Maryland, United States, 20814 Mexico Dr. Frank Arguello Cancer Clinic San Jose del Cabo, Baja California Sur, Mexico Instituto de Ciencia y Medicina Genomica Torreon, Coahuila, Mexico 收起 <<
NCT00552448	Pediatric, Asthma, Acute Exace... 展开 >>rbation, Pediatric ICU 收起 <<	Not Applicable	Terminated(Continuing review n... 展开 >>ot submitted to IRB within 365 days.) 收起 <<	-	United States, New York ... 展开 >> Stony Brook University Medical Center Stony Brook, New York, United States, 11794 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Texas Texas Tech University Health Sciences Center Lubbock, Texas, United States, 79430 收起 <<
NCT00711230	HIV Infection	Phase 2	Unknown	January 2015	Germany ... 展开 >> ifi-Medizin GmbH at the Asklepios Klinik St. Georg Hamburg, Germany, 20099 ICH Grindel Hamburg, Germany, 20146 University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20249 收起 <<
NCT00552448	-		Terminated(Continuing review n... 展开 >>ot submitted to IRB within 365 days.) 收起 <<	-	-
NCT02028065	-		Completed	-	-
NCT03352856	Allergy;Food ... 展开 >>Allergy Wheat 收起 <<	Not Applicable	Suspended(Recruitment challeng... 展开 >>es) 收起 <<	March 31, 2019	Finland ... 展开 >> Tampere University Hospital Tampere, Finland, 33520 收起 <<
NCT01847131	-		Completed	-	-
NCT00450463	-		Completed	-	-
NCT01383941	-		Completed	-	United States, Colorado ... 展开 >> National Jewish Health Denver, Colorado, United States, 80206 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States, 02118 United States, Michigan Henry Ford Health Center Detroit, Michigan, United States, 48202 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45202 United States, Texas University of Texas Southwestern Medical School Dallas, Texas, United States, 75390 收起 <<
NCT03158831	Drug Hypersensitivity ... 展开 >> Penicillin Allergy Antibiotic Allergy 收起 <<	Phase 1	Active, not recruiting	December 2018	United States, New York ... 展开 >> Montefiore Medical Center Bronx, New York, United States, 10461 收起 <<
NCT00712530	-		Completed	-	-
NCT01847131	Nasal Obstruction Present Find... 展开 >>ing 收起 <<	Phase 4	Completed	-	Thailand ... 展开 >> Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok, Thailand, 10700 收起 <<
NCT02236481	Diabetes Mellitus, Type 2 ... 展开 >> Arthritis, Rheumatoid 收起 <<	Phase 4	Terminated(Decision of the Spo... 展开 >>nsor for Early Benefits) 收起 <<	-	Italy ... 展开 >> L'Aquila University L'Aquila, Italy, 67100 收起 <<
NCT02382575	Nephrotic Syndrome	Phase 4	Recruiting	December 2018	India ... 展开 >> NRS Medical College & Hospital Recruiting Kolkata, West Bengal, India, 700014 Contact: Biswanath Basu 009123456731 ext 1804 basuv3000@gmail.com Principal Investigator: Biswanath Basu 收起 <<
NCT00712530	HIV Infection	Phase 1	Completed	-	Hungary ... 展开 >> Saint Laszlo Hospital Budapest, Hungary, 1097 收起 <<
NCT00200577	Melanoma	Phase 3	Completed	-	France ... 展开 >> CHU Angers Angers, France CHU Caen Caen, France Grenoble University Hospital Grenoble, France CH Le Mans Le Mans, France Montpellier University Hospital Montpellier, France Nantes University Hospital Nantes, France, 44093 CHU Poitiers Poitiers, France CHU Rennes Rennes, France CHRU Tours Tours, France 收起 <<
NCT02028065	Hypersensitivity ... 展开 >> Anaphylaxis 收起 <<	Phase 1	Completed	-	-
NCT00201331	Colonic Diseases ... 展开 >> Adenocarcinoma 收起 <<	Phase 2	Unknown	-	Taiwan ... 展开 >> Chang Gung Memorial Hospital Recruiting Tao-Yuan, Taiwan, 333 Contact: Tsai-Sheng Yang, MD 886-3-3281200 ext 2114 a481124@adm.cgmh.org.tw 收起 <<
NCT00003063	Colorectal Cancer	Phase 3	Unknown	-	-
NCT00002551	Colorectal Cancer	Phase 3	Completed	-	-
NCT02704806	-		Unknown	April 2018	-
NCT00309530	Colon Cancer Stage III	Phase 3	Completed	-	Austria ... 展开 >> Hospital Guessing Guessing, Burgenland, Austria, 7540 Hospital Oberpullendorf Oberpullendorf, Burgenland, Austria, 7350 Hospital BHB St. Veit/Glan, Surgery St. Veit a. d. Glan, Carinthia, Austria, 9330 State Hospital Wolfsberg Wolfsberg, Carinthia, Austria, 9400 Medical University of Graz, Oncology Graz, Styria, Austria, 8036 State Hospital Leoben, Surgery Leoben, Styria, Austria, 8700 Hospital St. Vinzenz Zams, Tyrol, Austria, 6511 State Hospital Kirchdorf Kirchdorf, Upper Austria, Austria, 4560 General Hospital Linz Linz, Upper Austria, Austria, 4020 Hospital BHB Linz Linz, Upper Austria, Austria, 4020 State Hospital Voecklabruck, Internal Medicine Voecklabruck, Upper Austria, Austria, 4840 Hospital Kreuzschwestern Wels Wels, Upper Austria, Austria, 4600 State Hospital Feldkirch Feldkirch, Vorarlberg, Austria, 6807 Paracelsus Medical University Salzburg - Oncology Salzburg, Austria, 5020 Medical University Vienna, General Hospital Vienna, Austria, 1090 Wilheminenspital, Internal Medicin I Vienna, Austria, 1160 收起 <<
NCT02438982	Nephrotic Syndrome	Phase 3	Completed	-	India ... 展开 >> NRS Medical College & Hospital Kolkata, West Bengal, India, 700014 收起 <<
NCT02203396	Aplastic Anemia	Phase 2	Unknown	September 2017	China, Tianjin ... 展开 >> Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences Recruiting TianJin, Tianjin, China, 300020 Contact: Nie Neng +86 22 23909023 docnn@163.com Principal Investigator: Zheng Yizhou, M.D., Ph.D 收起 <<
NCT00002593	Colorectal Cancer	Phase 3	Completed	-	-
NCT01760096	Paroxysmal Nocturnal Hemoglobi... 展开 >>nuria Hemoglobinuria Hemoglobinuria, Paroxysmal Proteinuria Urination Disorders Thrombosis Bone Marrow Failure Aplastic Anemia, Anemia, Hemolytic 收起 <<	Phase 2	Unknown	July 2017	China, Tianjin ... 展开 >> Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China, 300020 收起 <<
NCT01579110	Anemia Anemia... 展开 >>, Hemolytic Anemia, Hemolytic, Autoimmune Hemolysis Hematologic Diseases Autoimmune Diseases Immune System Diseases Pathologic Processes 收起 <<	Phase 2	Unknown	April 2016	China, Tianjin ... 展开 >> Blood Diseases Hospital Chinese Academy of Medical Sciences TianJin, Tianjin, China, 300020 收起 <<
NCT01642979	Paroxysmal Nocturnal Hemoglobi... 展开 >>nuria Hemoglobinuria Hemoglobinuria, Paroxysmal Proteinuria Urination Disorders Thrombosis Bone Marrow Failure Aplastic Anemia, Anemia, Hemolytic 收起 <<	Phase 2	Unknown	July 2017	China, Tianjin ... 展开 >> Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin, China, 300020 收起 <<
NCT01348321	Acne	Phase 2 Phase 3	Completed	-	Iran, Islamic Republic of ... 展开 >> Azadegan Street,Imam Hospital,Department of Dermatology Ahvaz, Khoozestan, Iran, Islamic Republic of, 6193673166 收起 <<
NCT00425152	Colorectal Cancer	Phase 3	Completed	-	-
NCT00705692	Renal Dialysis	Phase 2	Completed	-	Iran, Islamic Republic of ... 展开 >> Faghihi Hospital Hemodialysis Center, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of, 1978 - 71345 收起 <<
NCT03218657	Aplastic Anemia	Not Applicable	Recruiting	July 1, 2022	China, Zhejiang ... 展开 >> Zhejiang Province Traditional Chinese Medical Hospital Recruiting Hangzhou, Zhejiang, China, 310006 Contact: Lin s Yun, master 13588887285 lsyww2003@163.com 收起 <<
NCT00659997	Ascariasis Tr... 展开 >>ichuriasis 收起 <<	Phase 4	Completed	-	Tanzania ... 展开 >> Helminth Control Laboratory Unguja Stone Town, Tanzania 收起 <<
NCT02818738	First Manifestation of Steroid... 展开 >> Sensitive Nephrotic Syndrome 收起 <<	Phase 3	Recruiting	November 2020	France ... 展开 >> Hôpital Robert Debré Recruiting Paris, France, 75019 Contact: Claire DOSSIER, MD 01 40 03 24 67 ext +33 claire.dossier@aphp.fr Contact: Georges DESCHENES, MD PDH 01 40 03 24 67 ext +33 georges.deschenes@aphp.fr 收起 <<

盐酸左旋咪唑 /Levamisole HCI {[allProObj[0].p_purity_real_show]}

Levamisole HCI 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Levamisole HCI 质控信息

Levamisole HCI 生物活性

Levamisole HCI 临床研究

Levamisole HCI 参考文献

Levamisole HCI 实验方案

Levamisole HCI 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

盐酸左旋咪唑 /Levamisole HCI {[allProObj[0].p_purity_real_show]}

Levamisole HCI 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Levamisole HCI 质控信息

Levamisole HCI 生物活性

Levamisole HCI 临床研究

Levamisole HCI 参考文献

Levamisole HCI 实验方案

Levamisole HCI 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Levamisole HCI 纯度/质量文件产品仅供科研